What is Intergalactic Therapeutics?
Headquartered in Boston, Massachusetts, Intergalactic Therapeutics operates at the intersection of advanced research and development. With a lean, agile team of 20 to 49 professionals, the organization has demonstrated robust operational efficiency, generating annual revenues between 5M and 10M. The company focuses on high-impact scientific discovery, leveraging its strategic location in one of the world's premier life sciences hubs to drive innovation. By maintaining a specialized focus on R&D, Intergalactic Therapeutics has carved out a distinct market position, effectively bridging the gap between early-stage laboratory experimentation and scalable enterprise-level solutions.
How much funding has Intergalactic Therapeutics raised?
Intergalactic Therapeutics has raised a total of $75M across 1 funding round:
Series A
$75M
Series A (2021): $75M with participation from ATP
Key Investors in Intergalactic Therapeutics
ATP
ATP is a partner of aviation manufacturers, operators and maintenance providers focused on maximizing the value of aircraft and aviation operations by providing a suite of reference content, airworthiness, diagnostics and reliability services that optimize aircraft availability and operational compliance.
What's next for Intergalactic Therapeutics?
The recent influx of capital is expected to catalyze the next phase of the company's growth trajectory. By prioritizing the expansion of its core research capabilities, Intergalactic Therapeutics aims to transition from its current operational scale toward broader market penetration. Strategic priorities likely include the optimization of internal R&D workflows, the acquisition of specialized talent, and the potential acceleration of its proprietary pipeline. As the firm navigates this major enterprise-level funding phase, the focus will remain on achieving critical milestones that validate its scientific methodology and enhance its overall valuation in the global therapeutics market.
See full Intergalactic Therapeutics company page
